| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 07/30/2002 | US6426367 Methods for selectively occluding blood supplies to neoplasias |
| 07/30/2002 | US6426145 Radiopaque compositions for visualization of medical devices |
| 07/30/2002 | US6426059 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 07/30/2002 | US6426058 Such as xenon and helium are used to enhance and improve nuclear magnetic resonance (nmr) and magnetic resonance imaging (mri) |
| 07/30/2002 | CA2344707C N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives |
| 07/30/2002 | CA2103554C Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates, processes for their preparation, and use as contrast agents |
| 07/25/2002 | WO2002057741A2 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc) |
| 07/25/2002 | WO2002057499A2 Mdr1 variants and methods for their use |
| 07/25/2002 | WO2002057492A1 Methods and compositions for detecting polynucleotide duplex damage |
| 07/25/2002 | WO2002057417A2 Angiogenesis gene and modulators |
| 07/25/2002 | WO2002056919A2 Visual marker for determining compliance with a medication regimen |
| 07/25/2002 | WO2002056880A1 Triphenylmethane kinesin inhibitors |
| 07/25/2002 | WO2002007846A8 Extended organic cobalt and nickel magnetic complexes |
| 07/25/2002 | WO2002003048A8 Methylene blue diagnostic agent and diagnostic methods for detection of epithelial cancer |
| 07/25/2002 | WO2002002147A3 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 07/25/2002 | WO2001085010A3 Medical optical imaging scanner using multiple wavelength simultaneous data acquisition for breast imaging |
| 07/25/2002 | WO2001067955A3 Diagnostic procedures using direct injection of gaseous hyperpolarized 129xe and associated systems and products |
| 07/25/2002 | US20020099184 Radiolabeled compounds useful as imaging agents for visualizing the location and density of serotonin transporter by tomography imaging; as diagnostic and therapeutic agents for diseases associated with serotonin transporter dysfunction |
| 07/25/2002 | US20020098529 Detecting cells expressing preferential particles; obtain cells, mix with coated nanostructures, detect cells with bound nanostructures |
| 07/25/2002 | US20020098153 Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits |
| 07/25/2002 | US20020098152 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents |
| 07/25/2002 | US20020098151 Injectable ultrasound contrast agent, suspension of gas filled microbubbles or microballoons in physiologically accepted aqueous carrier, surfactants, additives and stabilizers |
| 07/25/2002 | US20020098149 Tetraaza or hexaaza tricylic derivatives or salts containing radionuclide; useful as x-ray or MRI contrast agent |
| 07/25/2002 | CA2434029A1 Visual marker for determining compliance with a medication regimen |
| 07/25/2002 | CA2427643A1 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc) |
| 07/24/2002 | EP1224861A1 Animal with the mass expression of human gene and test method by using the animal |
| 07/24/2002 | EP1224461A2 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease |
| 07/24/2002 | EP1224215A1 NON-ANAPHYLACTIC FORMS OF GRASS POLLEN Ph1 p 6 ALLERGEN AND THEIR USE |
| 07/24/2002 | EP1223986A2 Hydrogels derived from chitosan and poly(ethylene glycol) |
| 07/24/2002 | EP1223945A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 07/24/2002 | EP1223925A2 Use of a fatty acid derivative for the treatment of external secretion disorders |
| 07/24/2002 | EP0946203B1 Tricyclic functional dyes for contrast enhancement in optical imaging |
| 07/24/2002 | EP0836485B1 Cascade polymer complexes |
| 07/24/2002 | EP0821593B1 Conjugate of an active agent, a polyether and possibly a native protein regarded as acceptable by the body |
| 07/24/2002 | EP0760809B1 Application of omega-hydrofluoroalkyl ethers |
| 07/24/2002 | EP0719340B1 Cloned glutamic acid decarboxylase |
| 07/24/2002 | CN1087954C Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients |
| 07/23/2002 | US6424857 Medical diagnosis |
| 07/23/2002 | US6423547 Non-covalent bioconjugates useful for diagnosis and therapy |
| 07/23/2002 | US6423387 Bags having multilayer walls of polymers, deuterated polymers and metal films; materials handling; inert gases |
| 07/23/2002 | US6423296 Constrast media |
| 07/18/2002 | WO2002055742A2 Rapid method for screening compounds for in vivo activity |
| 07/18/2002 | WO2002055544A2 Fibrin binding polypeptides useful inter alia in medical imaging processes |
| 07/18/2002 | WO2002055112A2 Polypodal chelants for metallopharmaceuticals |
| 07/18/2002 | WO2002055111A2 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent |
| 07/18/2002 | WO2002055089A2 Immunoassay technique using multispecific molecules |
| 07/18/2002 | WO2002055027A2 Placebo effect and relaxation response |
| 07/18/2002 | WO2002006287A9 Macrocyclic mri contrast agents |
| 07/18/2002 | WO2002002633A3 Transporters and ion channels |
| 07/18/2002 | WO2001094391A3 Intracellular signaling proteins |
| 07/18/2002 | WO2001085790A3 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 07/18/2002 | WO2001079468A3 Drug metabolizing enzymes |
| 07/18/2002 | WO2001068142A9 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 07/18/2002 | WO2001059452A3 Method for diagnosing efficacy of xenotypic antibody therapy |
| 07/18/2002 | US20020095072 Combination and method including a visual marker for determining compliance with a medication regimen |
| 07/18/2002 | US20020095053 Di-lower-alkyl-5-nitroisophthalate reacts with a dihydroxy-monoalkylamine in the presence of a basic catalyst and then catalylytically hydrogenated, without isolating the 5-nitro-N,N'-bis(R)isophthalamide intermediate |
| 07/18/2002 | US20020094327 Increasing concentration of a SDF-1 alpha protein or SDF-1 alpha agonist in target tissue |
| 07/18/2002 | US20020094317 Such as xenon and helium are used to enhance and improve nuclear magnetic resonance (NMR) and magnetic resonance imaging (MRI) |
| 07/18/2002 | US20020094316 Polypodal chelants for metallopharmaceuticals |
| 07/18/2002 | DE10151791A1 Material recognizable by magnetic resonance, useful e.g. in drug delivery devices, comprises adduct of active agent, contrast agent and carrier, embedded in matrix |
| 07/18/2002 | CA2429956A1 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent |
| 07/17/2002 | EP1221977A2 Tumor detection by imaging and therapy of tumors |
| 07/17/2002 | EP1221975A2 Polymer stabilized neuropeptides |
| 07/17/2002 | EP1221974A2 Magnetic targeted carrier |
| 07/17/2002 | EP0837641A4 Coatings for production of hyperpolarized noble gases |
| 07/17/2002 | EP0713602B1 Use of polysaccharide covered superparamagnetic oxide colloids |
| 07/17/2002 | CN1359301A Prevention and treatment of amyloidogenic disease |
| 07/17/2002 | CN1359276A Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response |
| 07/17/2002 | CN1087628C Developer for supersonic diagnosis of oviduct and its use |
| 07/16/2002 | US6421455 Spectroscopy; applying aminolevulinic acid to skins |
| 07/16/2002 | US6420542 Tie ligands |
| 07/16/2002 | US6420436 Imaging contrast media and methods of use |
| 07/16/2002 | US6419897 Porphyrin compounds |
| 07/16/2002 | CA2095926C Anti-human milk fat globule humanised antibodies |
| 07/11/2002 | WO2002054088A2 Contrast enhancement agent for magnetic resonance imaging |
| 07/11/2002 | WO2002053596A2 Antibodies to insulin-like growth factor i receptor |
| 07/11/2002 | WO2002053570A1 Paramagnetic metal-phthalocyanine complex compounds and contrast agent using the same |
| 07/11/2002 | WO2002053093A2 Regulation of eating habits |
| 07/11/2002 | WO2002020724A3 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 07/11/2002 | WO2001076556A3 Lipid-based drug delivery systems against parasitic infections |
| 07/11/2002 | WO2001030397A3 Ultrasound inducement of artial and ventricular rhythms |
| 07/11/2002 | US20020090690 Semipermeable membrane for use in evaluating activity of anticarcinogenic agents on cells |
| 07/11/2002 | US20020090659 Detection and visualization of neoplastic tissues and other tissues |
| 07/11/2002 | US20020090342 For use in therapy, medical diagnosis, as contrast agents in mangetic resonance imaging, x-rays and tompgraphy |
| 07/11/2002 | US20020090341 Administering dosage of manganese complex or its salt and subjecting body to magnetic resonance imaging procedure capable of generating images to provide images of mycocardium to detect ischemia |
| 07/11/2002 | US20020090340 B/B-like fragment targeting for the purposes of photodynamic therapy and medical imaging |
| 07/11/2002 | US20020090339 Novel high viscosity embolizing compositions |
| 07/11/2002 | DE10064467A1 Lithium-Komplexe von N-(1-Hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecan, deren Herstellung und Verwendung Lithium complexes of N- (1-hydroxymethyl-2,3-dihydroxypropyl) -1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, their production and use |
| 07/11/2002 | CA2433800A1 Antibodies to insulin-like growth factor i receptor |
| 07/11/2002 | CA2433657A1 Contrast enhancement agent for magnetic resonance imaging |
| 07/10/2002 | EP1221283A2 Transgenic animal for screening therapeutic agents for brain tumors |
| 07/10/2002 | EP1220682A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 07/10/2002 | EP1024838B1 Stable radioiodine conjugates and methods for their synthesis |
| 07/10/2002 | CN1087178C Isotopic urea tablets |
| 07/09/2002 | US6417354 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid |
| 07/09/2002 | US6417178 Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits |
| 07/09/2002 | US6417003 Method and kit for epithelial cancer screening |
| 07/09/2002 | US6416960 Detection and visualization of neoplastic tissues and other tissues |
| 07/09/2002 | US6416741 Preparation of further diagnostic agents |
| 07/09/2002 | US6416739 Microparticles and their therapeutic or diagnostic use |